Selen and Cancer Diseases;Selen und Tumorerkrankungen

Aktuelle Ernahrungsmedizin

Volumn 21, Issue 2, 1996, Pages 103-113

  Kramer K ^a,e   Look, M P ^b   Chrissafidou, A ^b   Karsten, S ^c   Arends, J ^d  

^a G N PHARM Arzneimittel GmbH   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c B Braun Melsungen AG   (Germany)

^d TUMOR BIOLOGY CENTER   (Germany)

^e BASF SE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2742612489     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (119)

1. Abello, P. A., S. A. Filder, G. B. Bulkley, T. G. Buchman: Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Archs. Surg. 129 (1994) 134-141
2. Ahn, H., E. Lee, K. Kim, C. Lee: Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J. Urol. 151 (1994) 263-267
3. Alderton, P. M., J. Gross, M. D. Green: Comparative study of doxorubicin, mitoxantrone, epirubicin in combination with ICF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res. 52 (1992) 194-210
4. Ames, B. N., M. K. Shigenaga, T. M. Hagen: Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natn. Acad. Sci. USA 90 (1993) 7915-7922
5. Arthur, J. R., F. Nicol, G. J. Beckett: Hepatic iodothyronine 5′ deiodinase. The role of selenium. Biochem. J. 272 (1990) 537-540
6. Baldew, G. S., C. J. A. van den Hamer, G. Los, N. P. E. Vermeulen, J. J. M. de Goeij, J. G. McVie: Selenium-induced protection against cis-diamminedichloroplatinum (II) nephrotoxicity in mice and rats. Cancer Res. 49 (1989) 3020-3023
7. Batist, G., A. G. Katki, R. W. Klecker Jr., C. E. Myers: Selenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathione. Cancer Res. 46 (1986) 5482-5485
8. Behne, D., A. Kyriakopoulos, H. Meinhold, J. Köhrle: Identification of type I iodothyronine 5′ deiodinase as a selenoenzyme. Biochem. biophys. Res. Commun. 173 (1990) 1143-1149
9. Behne, D., A. Kyriakopoulos: Neue Selenproteine. Medsche. Klin. 90 (Suppl. 1) (1995) 5-7
10. Bendich, A.: Vitamin E and human functions. In: Klurfeld, D. M. (Eds.): Human Nutrition - A Comprehensive Treatise. Vol. 8, Nutrition and Immunolog. Plenum Press: New York (1993) 217-228
11. Bergelson, S., R. Pinkus, V. Daniel: Intracellular glutathione levels regulate fos/jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54 (1994) 36-40
12. Bianchi, L., A. Bianchi, F. Tateo, R. Pizzala, L. Stivala, L. Santamaria: Reduction of chromosomal damage by bleomycin in Lymphocytes from subjects supplemented with carotenoids. Relevance in bleomycin tumor therapy. Boll. Chim. Farm. 129 (1990) 83-87
13. Blot, W. J., J.-Y. Li, P. R. Taylor, W. Guo, S. Dawsey, G.-Q. Wang, C. S. Yang, S. F. Zheng, M. Gail, G.-Y. Li, Y. Yu, B.-q. Liu, J. Tangrea, Y.-h. Sun, F., Liu, J. F. Fraumeni, Jr., Y.-H. Zhang, B. Li: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natn. Cancer Inst 85 (1993) 1483-1492
14. Böck, A., K. Forchhammer, J. Heider, Ch. Baron: Selenoprotein synthesis: an expansion of the genetic code. TIBS 16 (1991) 463 -467
15. Böhles, H.: Radikalerkrankungen. Die Bedeutung von Sauerstoffradikalen für die klinische Medizin. Z. Geriatrie 4 (1991) 358-372
16. Bratakos, M. S., T. P. Vouterakos, P. V. Ioannou: Selenium status of cancer patients in Greece. Sci. Total Environ. 92 (1990) 207-222
17. Breccia, A., R. Badiello, A. Trenta, M. Mattii: On the chemical radioprotection by organic selenium compounds in vivo. Radiation Res. 38 (1969) 483-492
18. Carney, D. N.: The pharmacology of intravenous and oral etoposide. Cancer 67 (Suppl.) (1990) 299-302
19. Cerutti, P., R. Ghosh, G. Shah, P. Amstad: Oxidant stress in tumor promotion. 40th Harden Conference. Regulation of Gene Expression by Oxidative Stress: Implications for Health and Disease. Aviemore, U. K. (1993) 41 (Abstract)
20. Chrissafidou, A.: Untersuchungen zum Selenstatus bei Tumorpatienten und Analyse seiner Einflußfaktoren. Dissertation Medizinische Fakultät der Universität Bonn (1992)
21. Christensen, M. J., N. W. Pusey: Binding of nuclear proteins to transcription regulatory elements in selenium deficiency. BBA 1225 (1994) 338-341
22. Clark, L. C.: The epidemiology of selenium and cancer. Fed. Proc. 44 (1985) 2584-2589
23. Clemens, M. R., C. Ladner, G. Ehninger, H. Einsele, W. Renn, E. Bühler, H. D. Waller, K. F. Gey: Plasma vitamin E and β-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am. J. clin. Nutr. 51 (1990) 216-219
24. Clemens, M. R., C. I. Müller-Ladner, K. F. Gey: Vitamine bei hochdosierter Chemo- und Strahlentherapie. Z. Ernährwiss. 31 (1992) 110-120
25. Clemens, M. R., K. Bublitz, M. Leibfarth, C. I. Müller-Ladner: Einflüsse von Chemotherapie und Strahlenbelastung auf den Antioxidanzienstatus. VitaMinSpur 9 (1994) 76-81
26. Combs, G. F. Jr., S. B. Combs: The role of selenium in nutrition. Academic Press, Inc.: Orlando (1986)
27. Deutsche Gesellschaft für Ernährung: Empfehlungen für die Nährstoffzufuhr. 5. Überarbeitung. Umschau-Verlag, Frankfurt (1991)
28. Dimitrov, N. V., M. B. Hay, S. Siew, D. A. Hudler, L. J. Charamella, D. E. Ullrey: Abrogation of adnamycin-induced cardiotoxicity by selenium in rabbits. Am. J. Path. 126 (1987) 376-383
29. Djujic, J., O. Jozanov-Stankov, M. Demajo, M. Mandic: Effects of selenous yeast and ionizing radiation on trace elements and antioxidant defence system in erythrocytes. 4th International Congress on Trace Elements in Medicine and Biology: Trace Elements and Free Radicals in Oxidative Diseases. Chamonix, France April 5th-9th (1993) (Abstract)
30. Doll, R., R. Peto: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natn. Cancer Inst. 66 (1981) 1191-1208
31. Doroshow, J. H., S. Akman, F.-F. Chu, S. Esworthy: Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones. Pharm. Ther. 47 (1990) 359-370
32. Elstner, E. F.: Der Sauerstoff, Biochemie, Biologie, Medizin. B.I. Wissenschaftsverlag: Mannheim (1990) 283-284
33. Erdinger, U., W. Stelte: Spurenelement- und Magnesiumversorgung in der Bundesrepublik Deutschland. Ernähr.-Umsch. 39 (1992) 203-210
34. Esterbauer, H.: Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. clin. Nutr. 57 (Suppl.) (1993) 779-786
35. 1-adrenergic and other agonist. Rev. Physiol. Biochem. Pharmacol. 111 (1988) 117-224
36. Facchinetti, T., F. Delaini, M. Salmona, M. B. Donati, S. Feuerstein, A. Wendel: The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rats. Toxicol. Lett. 15 (1983) 301-307
37. Ferrara, A., M. M. McMillen, G. H. Ballantyne: T-cell subpopulations and colorectal cancer. Dis. Colon Rectum 33 (1990) 367-369
38. Flagg, E. W., R. J. Coates, J. W. Eley, D. P. Jones, E. W. Gunter, T. E. Byers, G. S. Block, R. S. Greenberg: Dietary glutathione intake in humans and the relationship between intake and plasma total glutathione level. Nutr. Cancer 21 (1994) 33-46
39. Forance, A. J.: DNA-damage-inducible genes in mammalian cells and the role for the p53 tumor suppressor in their regulation. 40th Harden Conference. Regulation of Gene Expression by Oxidative Stress: Implications for Health and Disease. Aviemore, U. K. (1993) 25 (Abstract)
40. Garland, M., W. C. Willet, J. E. Manson, D. J. Hunter: Antioxidant micronutrients and breast cancer. J. Am. Coll. Nutr. 12 (1993) 400-411
41. Gong, Y., G. D. Frenkel: Effect of selenite on tumor cell invasiveness. Cancer Lett. 78 (1994) 195-199
42. Goria-Gatti, L., A. Iannone, A. Tomasi, G. Poli, E. Albano: In vitro and in vivo evidence for the formation of methyl radical from procarbazine: a spin trapping study. Carcinogenesis 13 (1992) 799-805
43. Grimm, S., P. A. Baeuerle: The inducible transcription factor NF-κB: structure-function relationship of its protein subunits. Biochem. J. 290 (1993) 297-308
44. Guyton, K. Z., T. W. Kensler: Oxidative mechanisms in carcinogenesis. Br. med. Bull. 49 (1993) 523-544
45. Haas, H. J.: Selenversorgung: ausreichend. In: Friedrich-Schiller-Universität Jena (Hrsg.): Defizite und Überschüsse an Mengen- und Spurenelementen in der Ernährung. 10. Jahrestagung der Gesellschaft für Mineralstoffe und Spurenelemente. 14. Arbeitstagung Mengen- und Spurenelemente. Verlag Harald Schubert: Leipzig (1994) 146-163
46. Halliwell, B., S. Chirico: Lipid peroxidation: its mechanism, measurement, and significance. Am. J. clin. Nutr. 57 (Suppl.) (1993) 715-725
47. Halliwell, B.: Free radicals and antioxidants: a personal view. Nutr. Rev. 52 (1994) 253-265
48. Harris, M. L., H. J. Schiller, P. M. Reilly, M. Donowitz, M. B. Grisham, G. B. Bulkley: Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenon? Pharmac Ther. 53 (1992) 375-408
49. Hartfiel, W., W. Schulte: Selenmangel in der Bundesrepublik Deutschland (II). Akt Ernähr. (1988) 77-82
50. Jiang, X.-R., M. G. Macey, H.-X. Lin, A. C. Newland: The anti-leukaemic effects and the mechanism of sodium selenite. Leukemia Res. 16 (1992) 347-352
51. Kalyanaraman, B., J. Nemec, K. Sinha: Characterization of free radicals produced during oxidation of etoposide (V-16) and its catechol and quinone derivatives. An ESR-study. Biochemistry 28 (1989) 4839-4864
52. Keller, U.: Pathophysiology of cancer cachexia. Support. Care Cancer 1 (1993) 290-294
53. Kiremidjian-Schumacher, L., M. Roy, H. I. Wishe, M. W. Cohen, G. Stotzky: Selenium and immune cell functions. I. Effect on lymphocyte proliferation and production of interleukin 1 and interleukin 2. Proc. Soc. exp. Biol. Med. 193 (1990) 136-142
54. Kiremidjian-Schumacher, L., M. Roy, H. I. Wishe, M. W. Cohen, G. Stotzky: Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol. Trace Elem. Res. 41 (1994) 115-127
55. Kogata, M., M. Kobayashi, M. Yamamura, K. Hioki, M. Yamamoto: Selenium levels in malignant and normal tissues of gastrointestinal cancer patients. J. clin. Biochem. Nutr. 5 (1988) 93-101
56. Kramer, R. A., J. Zakher, G. Kim: Role of glutathione redox cycle in acquired and de novo multidrug resistance. Science 241 (1988) 694-696
57. Kuchan, M. J., J. A. Milner: Influence of intracellular glutathione on selenite-mediated growth inhibition of canine mammary tumor cells. Cancer Res. 52 (1992) 1091-1095
58. Ladner, C., G. Ehninger, K. F. Gey, M. R. Clemens: Effect of etoposide (VP16-213) on lipid peroxidation and antioxidant status in a high-dose radiochemotherapy regimen. Cancer Chemother. Pharmacol. 25 (1989) 210-212
59. Lai, G.-M., J. A. Moscow, M. G. Alvarez, A. T. Fojo, S. E. Bates: Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Int. J. Cancer 49 (1991) 588-595
60. Lanfear, J., J. Fleming, L. Wu, G. Webster, P. R. Harrison: The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 15 (1994), 1387-1392
61. Liu, J. -Z., B.-Z. Zhang, J. A. Milner: Dietary selenite modifies glutathione metabolism and 7,12-dimethylbenz(a)anthracene conjugation in rats. J. Nutr. 124 (1994) 172-180
62. Longnecker, M. P., P. R. Taylor, O. A. Levander, S. M. Howe, C. Veillon, P. A. McAdam: Selenium in diet, blood and toenails in relation to human health in a seleniferous area. Am. J. clin. Nutr. 53 (1991) 1288-1294
63. Look, M. P., E. Musch: Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy 40 (1994) 8-15
64. Mans, D. R., M. V. Lafleur, E. J. Westmijze, I. R. Horn, D. Bets, G. J. Schuhuis, J. Lankelma, J. Retel: Reactions of glutathione with the catechol, the ortho-quinone and the semi-quinone free radical of etoposide. Consequences for DNA inactivation. Biochem. Pharmac. 43 (1992) 1761-1768
65. Markant, A., G. Rimbach, K. Krämer, H. Mayer, J. Pallauf: Entstehung, Wirkung und Nachweis reaktiver Sauerstoffradikale. Pharmazeut. Z. 26 (1995) 2313-2327
66. Mimnaugh, E. G., L. Dusre, J. Atwell, C. H. E. Meyers: Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-human breast tumor cells. Cancer Res. 49 (1989) 8-15
67. National Research Council: Recommended Dietary Allowances. 10th Edition. National Academy Press: Washington D. C. (1989)
68. 2+ in cell killing. Chem. Res. Toxicol. 3 (1990) 484-494
69. Oster, O.: Zum Selenstatus in der Bundesrepublik Deutschland. Universitätsverlag Jena: Jena (1992)
70. Patchen, M. L., T. J. MacVittie, J. F. Weiss: Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int. J. Radiation Oncol. Biol. Phys. 18 (1990) 1069-1075
71. Patterson, B. H., L. A. Zech, C. A. Swanson, O. A. Levander: Kinetic modelling of selenium in humans using stable isotope tracers. J. Trace Elem. Electrolytes Health Dis. 7 (1993) 117-120
72. Pawlowicz, Z., B. A. Zachara, U. Trafikowska, A. Maciag, E. Marchaluk, A. Nowicki: Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer. J. Trace Elem. Electrolytes Health Dis. 5 (1991) 275-277
73. Petrie, H. T., L. W. Klassen, H. D. Kay: Selenium and the immune response: 1.Modulation of alloreactive human lymphocyte functions in vitro. J. Leukocyte Biol. 45 (1989) 207-214
74. Petrie, H. T., L. W. Klassen, P. S. Klassen, J. R. O'Dell, H. D. Kay: Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell toxicity in vivo. J. Leukocyte Biol. 45 (1989) 215-220
75. Pfannhauser, W.: Selenaufnahme in Europa. In: Friedrich-Schiller-Universität Jena (Hrsg.): Defizite und Überschüsse an Mengen- und Spurenelementen in der Ernährung. 10. Jahrestagung der Gesellschaft für Mineralstoffe und Spurenelemente. 14. Arbeitstagung Mengen- und Spurenelemente. Verlag Harald Schubert: Leipzig (1994) 79-84
76. Pothier, L., W. W. Lane, A. Bhargava, C. Michielson, H. O. Douglass, Jr.: Plasma selenium levels in patients with advanced upper gastrointestinal cancer. Cancer 60 (1987) 2251-2260
77. Punnonen, K., M. Ahotupa, K. Asaishi, M. Hyöty, R. Kudo, R. Ounnonen: Antioxidant enzyme activities and oxidative stress in human breast cancer. J. Cancer. Res. clin. Oncol. 120 (1994) 374-377
78. Reiter, R. J.: Oxidative processes and antioxidative defense mechanisms in the aging of brain. FASEB J. 9 (1995) 526-533
79. Rice-Evans, C., R. Burdon: Free radical-lipid interactions and their pathological consequences. Prog. Lipid Res. 32 (1993) 71-110
80. Rinstad, J., B. K. Jacobson, S. Treli, Y. Thomassen: Serum selenium concentration associated with risk of cancer. J. clin. Path. 41 (1988) 454-457
81. Roe, D. A., C. J. Fuller: Carotinoids and immune function. In: Klurfeld, D. M. (Ed.): Human Nutrition - A Comprehensive Treatise. Vol. 8, Nutrition and Immunology. Plenum Press: New York (1993) 229-238
82. Rotruck, J. T. A., L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, W. G. Hoekstra: Selenium: biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588-590
83. Roy, M., L. Kiremidjian-Schumacher, H. I. Wishe, M. W. Cohen, G. Stotzky: Effect of selenium on the expression of high affinity interleukin 2 receptors. Proc. Soc. exp. Biol. Med. 200 (1992) 36-43
84. Roy, M., L. Kiremidjian-Schumacher, H. I. Wishe, M. W. Cohen, G. Stotzky: Supplementation with selenium and human immune cell functions. I. Effect on lymphocyte proliferation and interleukin 2 receptor expression. Biol. Trace Elem. Res. 41 (1994) 103-114
85. Salonen, J. T., G. Alfthan, J. K. Huttunen, P. Puska: Association between serum selenium and the risk of cancer. Am. J. Epidemiol. 120 (1984) 342-349
86. Sangeeta, U. N., R. Koratkar, P. Suryaprabha: Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer. Free Rad. Biol. Med. 8 (1990) 15-19
87. Schrauzer, G. N.: Selenium. Mechanistic aspects of anticarcinogenic action. Biol. Trace Elem. Res. 33 (1992) 51-62
88. Schreck, R., K. Albermann, P. Baeuerle: Nuclear factor κB: an oxidative stress-response transcription factor of eukaryotic cells (a review). Free Rad. Res. Comms. 17 (1992) 221-237
89. Schwarz, K., C. M. Foltz: Selenium as an integral part of Factor 3 against dietary liver degeneration. J. Am. Chem. Soc. 79 (1957) 3292-3293
90. Shenberg, C., M. Boazi, J. Cohen, A. Klein, M. Kojler, A. Nyska: An XRF study of trace elements accumulation in kidneys of tumor-bearing mice after treatment with cis-DDP with and without selenite and selenocistamine. Biol. Trace Elem. Res. 40 (1994) 137-149
91. Shklar, G., J. Schwartz, D. Tricker, S. R. Cheverie: The effectiveness of a mixture of β-carotene, α-tocopherol, glutathione, and ascorbic acid for cancer prevention. Nutr. Cancer 20 (1993) 145-151
92. Siegel, B. V.: Vitamin C and the immune response in health and disease. In: Klurfeld, D. M. (Ed.): Human Nutrition - A Comprehensive Treatise. Vol. 8, Nutrition and Immunology. Plenum Press, New York (1993) 167-196
93. Sinha, B., E. G. Mimnaugh: Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors. Free Radic. Biol. Med. 8 (1990) 567-581
94. Sinha, B. K., P. M. Politi: Antracyclines. Cancer Chemother. Biol. Response Modif. 11 (1990) 45-57
95. Sokoloff, L.: Kaschin-Beck disease: current status. Nutr. Rev. 46 (1988) 113-119
96. Stabel, J. R., J. W. Spears: Role of selenium in immune responsiveness and disease resistance. In: Klurfeld, D. M. (Ed.): Human Nutrition - A Comprehensive Treatise. Vol. 8, Nutrition and Immunology. Plenum Press: New York (1993) 333-356
97. Stoffel, B., S. Takai, K. Krämer, H. L. Ko, J. Beuth, G. Pulverer: Murine thymocyte proliferation, maturation and emigration in response to selenium. Drug Res., in press
98. Sunde, R. A.: Intracellular glutathione peroxidases - structure, regulation and, function. In: Burk, R. F. (Ed.): Selenium in Biology and Human Health. Springer Verlag: New York (1994) 45 -77
99. Sundström, H., H. Korpela, E. Sajanti, A. Kauppila: Supplementation with selenium, vitamin E and their combination in gynaecological cancer during cytostatic chemotherapy. Carcinogenesis 10 (1989) 273-278
100. Timmer-Bosscha, H., N. H. Mulder, E. G. E. de Vries: Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br. J. Cancer 66 (1992) 227-238
101. Trump, B. F., I. K. Berezesky: Calcium-mediated cell injury and cell death. FASEB J. 9 (1995) 219-228
102. Turner, R. J., J. M. Finch: Selenium and the immune response. Proc. Nutr. Soc. 50 (1991) 275-285
103. Van Dael, P., H. Deelstra: Selenium: In: Flair Concerted Action No 10 Status Papers. Internat. J. Vit. Nutr. Res. 63 (1993) 247-316
104. Vanderpas, J. B., B. Contempre, N. L. Duale, H. Deckx, N. Bebe, A. O. Longombe, C. H. Thilly, A. T. Diplock, J. E. Dumont: Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am. J. clin. Nutr. 57 (1993) 271-275
105. Vermeulen, N. P. E., G. S. Baldew, G. Los, J. G. McVie, J. J. M. de Goeij: Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds. Drug Metabol. Dispos. 21 (1993) 30-36
106. Vernie, L. N., A. van Leewenhoekhuis: Inhibition of protean synthesis and anticarcinogenicity of selenium compounds. In: Combs, G. F. Jr., J. E. Spallholz, O. A. Levander, J. E. Oldfield (Eds.): Proceedings of the Third International Symposium on Selenium in Biology and Medicine. Avi Publ. Co.: Westport, Conn. (1987) 1074-1083
107. Volm, M. T. Efferth: Resistenzüberwindung bei Tumoren. D. Med. Wschr. 119 (1994) 475-479
108. Wadleigh, R. G., R. S. Redman, M. L. Graham, S. H. Krasnow, A. Anderson, M. H. Cohen: Vitamin E in the treatment of chemotherapy-induced mucositis. Am. J. Med. 92 (1992) 481-484
109. Weisberger, A. S., L. G. Suhrland: Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia. Blood 11 (1956) 19-30
110. Weiss, J. F., V. Srinivasan, K. S. Kumar, M. R. Landauer, M. L. Patchen: Radioprotection by selenium and other metals. 4th International Congress on Trace Elements in Medicine and Biology: Trace Elements and Free Radicals in Oxidative Diseases. Chamonix, France April 5th-9th (1993) (Abstract)
111. Witt, E. H., A. Z. Reznick, C. A. Viguie, P. Starke-Reed, L. Packer: Exercise, oxidative damage and effects of antioxidant manipulation. J. Nutr. 122 (1992) 766-773
112. Wolffram, S.: Absorption und Bioverfügbarkeit des Spurenelementes Selen Habilitationsschrift. Veterinär-Medizinische Fakultät der Universität Zürich (1991)
113. Wolffram, S.: Mechanismen der intestinalen Absorption von Selen. Medsche. Klinik 90 (Suppl. I) (1995) 1-5
114. Wolfram, G.: 1st der Wert der antioxidativen Vitamine etabliert? Internist 35 (1994) 1117-1123
115. Yan, L., J. E. Spallholz: Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Biochem. Pharmac. 45 (1993) 429-437
116. Yang, G., K. Ge, J. Chen, X. Chen: Selenium-related endemic diseases and the daily selenium requirement of humans. Wld. Rev. Nutr. Diet. 55 (1988) 98-152
117. Yang, G. Q., L. Z. Zhu, S. J. Liu: Human selenium requirements in china. In: Combs, G. F., J. E. Spallholz, O. A. Levander, J. E. Oldfield (Eds.): Selenium in Biology and Medicin. Van Nostrand Reinhold Co.: New York (1987) 589-605
118. Yang, G. Q., S.Wang, R. Zhou, R. Sun: Endemic selenium intoxication of humans in china. Am. J. clin. Nutr. 37 (1983) 872-881
119. Yu, S.-Y., Y.-S. Zhu, W.-G. Li, Q.-S. Huang, C. Zhi-Huang, Q.-N. Zhang, C. Hou: A preliminary report on the intervention trials of primary liver chancer in high-risk populations with nutritional supplementation of selenium in China. Biol. Trace Elem. Res. 29 (1991) 289-294